Your browser doesn't support javascript.
loading
Pooled rates of adenoma detection by colonoscopy in asymptomatic average-risk individuals with positive fecal immunochemical test: a systematic review and meta-analysis.
Mohan, Babu P; Khan, Shahab R; Daugherty, Evan; Chandan, Saurabh; Ponnada, Suresh; Facciorusso, Antonio; Kassab, Lena L; Asokkumar, Ravishankar; Adler, Douglas G.
Afiliação
  • Mohan BP; Department of Gastroenterology & Hepatology, Department of Medicine, University of Utah Health, Salt Lake City, Utah, USA.
  • Khan SR; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Daugherty E; Department of Internal Medicine, University of Utah Health, Salt Lake City, Utah, USA.
  • Chandan S; Department of Gastroenterology, Creighton University School of Medicine, Omaha, Nebraska, USA.
  • Ponnada S; Department of Internal Medicine, Roanoke Carilion Memorial Hospital, Roanoke, Virginia, USA.
  • Facciorusso A; Gastroenterology Unit, University of Foggia, Foggia, Italy.
  • Kassab LL; Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Asokkumar R; Department of Gastroenterology, Singapore General Hospital, Singapore.
  • Adler DG; Department of Gastroenterology, Center for Advanced Therapeutic Endoscopy, Denver, Colorado, USA.
Gastrointest Endosc ; 96(2): 208-222.e14, 2022 08.
Article em En | MEDLINE | ID: mdl-35413330
BACKGROUND AND AIMS: Current adenoma detection rate (ADR) benchmarks for colonoscopy in individuals positive for a fecal immunochemical test (FIT) are ≥45% in men and ≥35% in women. These are based on weak, low-quality evidence. We performed a meta-analysis to ascertain the pooled ADR in FIT-positive colonoscopy. METHODS: Major databases like PubMed, EMBASE, and Web of Science were searched in October 2021 for studies reporting on ADR of colonoscopy in a FIT-positive population. Meta-analysis was performed by standard methodology using the random-effects model. Heterogeneity was assessed by I2 and 95% prediction interval statistics. RESULTS: Thirty-four high-quality studies that included more than 6 million asymptomatic average-risk individuals were analyzed; 2,655,345 individuals completed a screening FIT test. The pooled FIT screening rate was 69.8% (95% CI, 62.8-76.1), the pooled FIT positivity rate was 5.4% (95% CI, 4.3-6.9), and the colonoscopy completion rate was 85% (95% CI, 82.8-86.9). The pooled ADR was 47.8% (95% CI, 44.1-51.6), pooled advanced ADR was 25.3% (95% CI, 22-29), and the pooled colorectal cancer detection rate was 5.1% (95% CI, 4.4-5.9). The pooled ADR in men was 58.3% (95% CI, 52.8-63.6) and in women was 41.9% (95% CI, 36.4-47.6). The pooled ADR with qualitative FIT assessment was 67.7% (95% CI, 50.7-81), with 1-stool sample FIT was 52.8% (95% CI, 48.8-56.8), and at a cutoff threshold of 100 ng hemoglobin/mL was 52.1% (95% CI, 47-57.1). Based on time-period cumulative analysis, the ADR improved over time from 30.5% (95% CI, 24.6-37.2) to 47.8% (95% CI, 44.1-51.6). CONCLUSIONS: This meta-analysis supports the current ADR benchmarks for colonoscopy in FIT-positive individuals. Excellent pooled ADR parameters were demonstrated with qualitative assessment of 1 stool sample at a test cutoff value of 100 ng hemoglobin/mL, and ADR per endoscopist improved over time.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Adenoma Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies / Screening_studies / Systematic_reviews Limite: Female / Humans / Male Idioma: En Revista: Gastrointest Endosc Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Adenoma Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies / Screening_studies / Systematic_reviews Limite: Female / Humans / Male Idioma: En Revista: Gastrointest Endosc Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos